BeyondSpring Inc. Ordinary Shares earnings per share and revenue
On --, BYSI reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
What were BeyondSpring Inc. Ordinary Shares's earnings and revenue for the latest quarter Q-- --?
For Q-- --, BeyondSpring Inc. Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to BeyondSpring Inc. Ordinary Shares's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is BeyondSpring Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for Mar 27, 2026.
What are the forecasts for BeyondSpring Inc. Ordinary Shares's next earnings report?
Based on --
analysts, BeyondSpring Inc. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q4 2025.